Is the early cyclosporine A level predictive of the outcome of immunosuppressive therapy in severe aplastic anemia?

European Journal of Haematology

Volumn 83, Issue 1, 2009, Pages 72-78

  Song, Moo Kon ^b   Chung, Joo Seop ^a,b   Joo, Young Don ^c   Kim, Yang Soo ^d   Kim, Sung Hyun ^e   Seol, Young Mi ^b   Shin, Ho Jin ^b   Choi, Young Jin ^b   Cho, Goon Jae ^b  

^a Pusan National University School of Medicine   (South Korea)

^b Pusan National University School of Medicine   (South Korea)

^c Inje University College of Medicine   (South Korea)

^d Kosin University   (South Korea)

^e Dong A University   (South Korea)

Author keywords

Anti thymocyte globulin; Aplastic anemia; Cyclosporine

Indexed keywords

CYCLOSPORIN A; PREDNISOLONE; THYMOCYTE ANTIBODY; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY;

ADULT; AGE; AGED; APLASTIC ANEMIA; ARTICLE; CLONE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG WITHDRAWAL; ERYTHROCYTE TRANSFUSION; FEMALE; GENDER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPHIL COUNT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; RELAPSE; RETICULOCYTE COUNT; RETROSPECTIVE STUDY; SERUM SICKNESS; SURVIVAL TIME; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; BLOOD; CLINICAL TRIAL; IMMUNOLOGY; KAPLAN MEIER METHOD; KOREA; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; T LYMPHOCYTE; TIME;

ADULT; AGED; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIERS ESTIMATE; KOREA; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; T-LYMPHOCYTES; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67649562293     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2009.01237.x     Document Type: Article

References (16)

1. Camitta BM, Doney K. Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results. Am J Pediatr Hematol Oncol 1990 12 : 411 24.
2. Champlin R, Ho W, Gale RP. Antilymphocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. N Engl J Med 1983 308 : 113 8.
3. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meusers P, Salama A, Heimpel H. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 1991 324 : 1297 304.
4. Marsh JC, Ball SE, Darbyshire P, et al. Guidelines for the diagnosis and management of acquired aplastic anemia. Br J Haematol 2003 123 : 782 801. (Pubitemid 37533290)
5. Frickhofen N, Heimpel H, Kaltwasser GP, Schrezmeier H. Antithymocyte globulin with or without cyclosporine A: 11-year follow-up of randomized trial comparing treatments of aplastic anemia. Blood 2003 101 : 1236 42.
6. Locasciulli A, Oneto R, Bacigalupo A, Socié G, Korthof E, Bekassy A, Schrezenmeier H, Passweg J, Führer M Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplant Group. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood an Marrow Transplantation (EBMT). Haematologica 2007 92 : 11 8.
7. Bacigalupo A, Hows J, Gluckman E, Nissen C, Marsh J, Van Lint MT, Congiu M, De Planque MM, Ernst P, McCann S. Bone marrow transplantation (BMT) versus immunosuppression (IS) for the treatment of severe aplastic anemia (SAA): a report of the EBMT SAA working party. Br J Haematol 1988 70 : 177 82.
8. Locasciulli A, Bruno B, Rambaldi A, et al. Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporin and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study. Haematologica 2004 89 : 1054 61.
9. Teramura M, Kimura A, Iwase S, Yonemura Y, Nakao S, Urabe A, Omine M, Mizoguchi H. Treatment of severe aplastic anemia with antithymocyte globulin and cyclosporin A with or without G-CSF in adults: a multicenter randomized study in Japan. Blood 2007 110 : 1756 61.
10. Rosenfeld S, Follman D, Nunez O, Young NS. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA 2003 289 : 1130 5.
11. Bacigalupo A, Brand R, Oneto R, et al. Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy - The European Group for Blood and Marrow transplantation experience (EBMT). Semin Hematol 2000 37 : 69 80. (Pubitemid 30080248)
12. Bacigalupo A, Bruno B, Saracco P, et al. Antilymphocyte globulin, cyclosporine, prednisolone, and granulocyte colony-stimulating factor for severe aplastic anemia: an update of the GITMO/EBMT study on 100 patients. European Group for Blood and Marrow Transplantation (EBMT) Working Party on Severe Aplastic Anemia and the Gruppo Italiano Trapianti di Midolio Osseo (GITMO). Blood 2000 95 : 1931 4.
13. Doney K, Pepe M, Storb R, Bryant E, Anasetti C, Appelbaum FR, Buckner CD, Sanders J, Singer J, Sullivan K. Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone. Blood 1992 79 : 2566 71.
14. de Planque MM, Kluin-Nelemans HC, van Krieken HJ, Kluin PM, Brand A, Beverstock GC, Willemze R, van Rood JJ. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults. Br J Haematol 1988 70 : 55 62. (Pubitemid 18219521)
15. Tichelli A, Gratwohl A, Wursch A, Nissen C, speck B. Late haematological complications in severe aplastic anemia. Br J Haematol 1988 69 : 413 8.
16. de Planque MM, Bacigalupo A, Würsch A, Hows JM, Devergie A, Frickhofen N, Brand A, Nissen C. Long-term follow-up of severe aplastic anemia patients treated with antithymocyte globulin. Severe Aplastic Anaemia Working Party of the European Cooperative Group for Bone Marrow Transplantation (EBMT). Br J Haematol 1989 73 : 121 6.